1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. mTOR

mTOR (哺乳动物雷帕霉素靶蛋白)

Mammalian target of Rapamycin

mTOR (mammalian target of Rapamycin) is a protein that in humans is encoded by the mTOR gene. mTOR is a serine/threonine protein kinase that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription. mTOR belongs to the phosphatidylinositol 3-kinase-related kinase protein family. mTOR integrates the input from upstream pathways, including growth factors and amino acids. mTOR also senses cellular nutrient, oxygen, and energy levels. The mTOR pathway is dysregulated in human diseases, such as diabetes, obesity, depression, and certain cancers. Rapamycin inhibits mTOR by associating with its intracellular receptor FKBP12. The FKBP12-rapamycin complex binds directly to the FKBP12-Rapamycin Binding (FRB) domain of mTOR, inhibiting its activity.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-10474
    Torkinib Inhibitor 98.37%
    Torkinib (PP 242) 是一种选择性,ATP 竞争型的 mTOR 抑制剂,IC50 为 8 nM。PP242 抑制 mTORC1mTORC2IC50 分别为 30 nM 和 58 nM。
    Torkinib
  • HY-10115
    PI-103 Inhibitor 98.93%
    PI-103 是一种有效的 PI3K mTOR 抑制剂,抑制 p110αp110βp110δp110γmTORC1mTORC2IC50 分别为 8 nM,88 nM,48 nM,150 nM,20 nM 和 83 nM。PI-103 还抑制 DNA-PK,IC50 为 2 nM。PI-103 诱导自噬 (autophagy)
    PI-103
  • HY-N0112
    Dihydromyricetin

    二氢杨梅素

    Inhibitor 98.10%
    Dihydromyricetin 是一种有效的二氢嘧啶酶 (dihydropyrimidinase) 抑制剂,IC50 为 48 μM。Dihydromyricetin 可通过抑制 mTOR 信号从而激活自噬。Dihydromyricetin 抑制 mTOR 复合体 (mTORC1/2) 形成。Dihydromyricetin 还是一种流感依赖 RNA 的 RNA 聚合酶抑制剂,IC50 为 22 μM。
    Dihydromyricetin
  • HY-114384
    NV-5138 Activator ≥98.0%
    NV-5138 是一种亮氨酸类似物,是首个具有选择性的、口服活性的脑内的 mTORC1 的激动剂,与 Sestrin2 结合。NV-5138 可用于抗抑郁的生物研究。
    NV-5138
  • HY-15247
    Vistusertib

    奥西替尼杂质1 (AZD2014)

    Inhibitor 98.21%
    Vistusertib (AZD2014) 是一种ATP竞争性的 mTOR 抑制剂,IC50 为 2.81 nM。AZD2014 抑制 mTORC1mTORC2 复合物。
    Vistusertib
  • HY-100542
    D-α-Hydroxyglutaric acid disodium

    (R)-2-羟基戊二酸二钠盐

    Inhibitor ≥98.0%
    D-α-Hydroxyglutaric acid disodium (Disodium (R)-2-hydroxyglutarate) 是神经代谢疾病 D-2-羟基戊二酸尿症中积累的主要代谢产物。D-α-Hydroxyglutaric acid disodium 是 α-酮戊二酸 (α-KG) 的弱竞争拮抗剂,可抑制多种 α-KG 依赖性双加氧酶 (dioxygenases),Ki 为 10.87 mM。D-α-Hydroxyglutaric acid disodium 可增加活性氧 (ROS) 的产生。D-α-Hydroxyglutaric acid disodium 还可结合并抑制 ATP 合酶并抑制 mTOR 信号传导。
    D-α-Hydroxyglutaric acid disodium
  • HY-124719
    hSMG-1 inhibitor 11j Inhibitor 99.81%
    hSMG-1 inhibitor 11j,一种嘧啶衍生物,是有效的和选择性的 hSMG-1 抑制剂,IC50 值为 0.11 nM。hSMG-1 inhibitor 11j 对 hSMG-1 的选择性是 mTOR (IC50=50 nM),PI3Kα (IC50=92/60 nM) 和 CDK1/CDK2 (IC50=32/7.1 μM) 的 455 倍以上。hSMG-1 inhibitor 11j 可用于癌症研究。
    hSMG-1 inhibitor 11j
  • HY-124798
    Rheb inhibitor NR1 Inhibitor 99.46%
    Rheb inhibitor NR1 是一种 Rheb 抑制剂,IC50 为 2.1 μM。Rheb inhibitor NR1 可直接结合 Rheb switch II 结构域,选择性抑制 mTORC1 的激活。Rheb inhibitor NR1 抑制 mTORC1 驱动的 T389pS6K1 的磷酸化,并以剂量依赖的方式增加 S473pAKT 的磷酸化。Rheb inhibitor NR1 不影响 mTORC2 的活性。
    Rheb inhibitor NR1
  • HY-N0047
    Polyphyllin I

    重楼皂苷I

    Inhibitor 99.61%
    Polyphyllin I 是一种从 Paris polyphylla 中提取的生物活性成分,具有很强的抗肿瘤活性。Polyphyllin I 是 JNK 信号通路的激活剂,也是 PDK1/Akt/mTOR 信号传导的抑制剂。Polyphyllin I 诱导自噬,G2/M 期阻滞和细胞凋亡。
    Polyphyllin I
  • HY-15177
    PF-04691502 Inhibitor 99.91%
    PF-04691502是有效和选择性的 PI3KmTOR 的抑制剂。 PF-04691502与人PI3Kα,β,δ,γ和mTOR结合的 Ki 分别为1.8,2.1,1.6,1.9和16 nM。
    PF-04691502
  • HY-N0189
    Aloe emodin

    芦荟大黄素

    Inhibitor 98.32%
    Aloe emodin (Rhabarberone) 是一种天然羟基蒽醌,具有抗肿瘤活性。 Aloe emodin (Rhabarberone) 可以与 mTORC2 结合并抑制其激酶活性。 Aloe emodin (Rhabarberone) 发挥抗增殖作用并诱导细胞凋亡 (apoptosis)。Aloe emodin (Rhabarberone) 还表现出针对甲型流感病毒 (influenza A virus) 的抗病毒活性。
    Aloe emodin
  • HY-50710
    KU-0063794 Inhibitor 99.55%
    KU-0063794 是一种有效的,特异性的 mTOR 抑制剂,能够抑制 mTORC1mTORC2IC50 值均约为 10 nM。
    KU-0063794
  • HY-N0787
    Cryptochlorogenic acid

    隐绿原酸

    Inhibitor 99.88%
    Cryptochlorogenic acid (4-Caffeoylquinic acid) 是一种具有口服有效性的天然存在的酚酸类化合物,具有抗炎、抗氧化和抗心肌肥大作用,能通过调控促炎因子表达、抑制 NF-κB 活性、促进 Nrf2 核转移以及调节 PI3Kα/Akt/ mTOR / HIF-1α 信号通路来减轻 LPS (HY-D1056) 和 ISO (HY-B0468) 诱导的生理应激反应。
    Cryptochlorogenic acid
  • HY-N0281
    Daphnetin

    瑞香素

    Inhibitor 99.86%
    Daphnetin (7,8-dihydroxycoumarin) 是一种香豆素衍生物,可来源于 Genus Daphne,是一种口服有效的蛋白激酶抑制剂 (protein kinase),对 EGFR、PKA 和 PKCIC50 值分别为 7.67 μM、9.33 μM 和 25.01 μM。Daphnetin 触发活性氧诱导的细胞凋亡 (apoptosis) 和通过调节 AMPK/Akt/mTOR 途径诱导细胞保护性自噬(autophagy)。Daphnetin 具有抗炎活性,并抑制 TNF-α、IL-1ß、ROS 和 MDA 的产生。Daphnetin 具有杀疟活性。瑞香素可用于类风湿关节炎、癌症和抗疟疾研究。
    Daphnetin
  • HY-12513
    Samotolisib Inhibitor 99.42%
    Samotolisib (LY3023414) 有效且选择性地抑制 PI3KαPI3KβPI3KδPI3KγDNA-PK,和 mTORIC50 分别为 6.07 nM,77.6 nM,38 nM,23.8 nM,4.24 nM,和 165 nM。在低纳摩尔浓度下,Samotolisib 有效抑制 mTORC1/2
    Samotolisib
  • HY-124760
    hSMG-1 inhibitor 11e Inhibitor 99.81%
    hSMG-1 inhibitor 11e 是一种有效的选择性的 hSMG-1 激酶抑制剂,其 IC50 值 <0.05 nM。hSMG-1 inhibitor 11e 对 hSMG-1 的选择性比 mTOR (IC50 为 45 nM),PI3Kα/γ (IC50 为 61 nM 和 92 nM) 和 CDK1/CDK2 (IC50 为 32 μM 和 7.1 μM) 高 900 倍。
    hSMG-1 inhibitor 11e
  • HY-114384B
    NV-5138 hydrochloride Activator ≥98.0%
    NV-5138 hydrochloride 是一种亮氨酸类似物,是首个具有选择性的、口服活性的脑内的 mTORC1 的激动剂,与 Sestrin2 结合。NV-5138 hydrochloride 可用于抗抑郁的生物研究。
    NV-5138 hydrochloride
  • HY-50908
    Ridaforolimus Inhibitor 99.20%
    Ridaforolimus (MK-8669) 是一种有效和选择性的 mTOR 抑制剂,在 HT-1080 细胞中抑制 S6 磷酸化的 IC50 值为 0.2 nM。
    Ridaforolimus
  • HY-15900
    Voxtalisib Inhibitor 98.81%
    Voxtalisib (XL765) 是一种有效的 PI3K 抑制剂,抑制p110αp110βp110γp110δIC50 分别为 39, 113, 9 和 43 nM,也抑制 DNA-PK (IC50=150 nM) 和 mTOR (IC50=157 nM)。Voxtalisib (XL765) 抑制 mTORC1mTORC2IC50s 分别为 160 和 910 nM。
    Voxtalisib
  • HY-15174
    Dactolisib Tosylate Inhibitor 99.87%
    Dactolisib Tosylate (BEZ235 Tosylate) 是PI3KmTOR的双重激酶抑制剂,对PI3Kα, β, γ, δ 的IC50值分别为4, 75, 7, 5 nM。Dactolisib Tosylate (BEZ235 Tosylate) 抑制 mTORC1mTORC2
    Dactolisib Tosylate
目录号 产品名 / 同用名 应用 反应物种

The mammalian target of rapamycin (mTOR) signaling pathway integrates both intracellular and extracellular signals and serves as a central regulator of cell metabolism, growth, proliferation and survival[1]. mTOR is the catalytic subunit of two distinct complexes called mTORC1 and mTORC2. mTORC1 comprises DEPTOR, PRAS40, RAPTOR, mLST8, mTOR, whereas mTORC2 comprises DEPTOR, mLST8, PROTOR, RICTOR, mSIN1, mTOR[2]. Rapamycin binds to FKBP12 and inhibits mTORC1 by disrupting the interaction between mTOR and RAPTOR. mTORC1 negatively regulates autophagy through multiple inputs, including inhibitory phosphorylation of ULK1 and TFEB. mTORC1 promotes protein synthesis through activation of the translation initiation promoter S6K and through inhibition of the inhibitory mRNA cap binding 4E-BP1, and regulates glycolysis through HIF-1α. It promotes de novo lipid synthesis through the SREBP transcription factors. mTORC2 inhibits FOXO1,3 through SGK and Akt, which can lead to increased longevity. The complex also regulates actin cytoskeleton assembly through PKC and Rho kinase[3]

 

Growth factors: Growth factors can signal to mTORC1 through both PI3K-Akt and Ras-Raf-MEK-ERK axis. For example, ERK and RSK phosphorylate TSC2, and inhibit it.

 

Insulin Receptor: The activated insulin receptor recruits intracellular adaptor protein IRS1. Phosphorylation of these proteins on tyrosine residues by the insulin receptor initiates the recruitment and activation of PI3K. PIP3 acts as a second messenger which promotes the phosphorylation of Akt and triggers the Akt-dependent multisite phosphorylation of TSC2. TSC is a heterotrimeric complex comprised of TSC1, TSC2, and TBC1D7, and functions as a GTPase activating protein (GAP) for the small GTPase Rheb, which directly binds and activates mTORC1. mTORC2 primarily functions as an effector of insulin/PI3K signaling. 

 

Wnt: The Wnt pathway activates mTORC1. Glycogen synthase kinase 3β (GSK-3β) acts as a negative regulator of mTORC1 by phosphorylating TSC2. mTORC2 is activated by Wnt in a manner dependent on the small GTPase RAC1[4].

 

Amino acids: mTORC1 senses both lysosomal and cytosolic amino acids through distinct mechanisms. Amino acids induce the movement of mTORC1 to lysosomal membranes, where the Rag proteins reside. A complex named Ragulator, interact with the Rag GTPases, recruits them to lysosomes through a mechanism dependent on the lysosomal v-ATPase, and is essential for mTORC1 activation. In turn, lysosomal recruitment enables mTORC1 to interact with GTP-bound RHEB, the end point of growth factor. Cytosolic leucine and arginine signal to mTORC1 through a distinct pathway comprised of the GATOR1 and GATOR2 complexes.    

 

Stresses: mTORC1 responds to intracellular and environmental stresses that are incompatible with growth such as low ATP levels, hypoxia, or DNA damage. A reduction in cellular energy charge, for example during glucose deprivation, activates the stress responsive metabolic regulator AMPK, which inhibits mTORC1 both indirectly, through phosphorylation and activation of TSC2, as well as directly through the phosphorylation of RAPTOR. Sestrin1/2 are two transcriptional targets of p53 that are implicated in the DNA damage response, and they potently activate AMPK, thus mediating the p53-dependent suppression of mTOR activity upon DNA damage. During hypoxia, mitochondrial respiration is impaired, leading to low ATP levels and activation of AMPK. Hypoxia also affects mTORC1 in AMPK-independent ways by inducing the expression of REDD1, the protein products of which then suppress mTORC1 by promoting the assembly of TSC1-TSC2[2].

 

Reference:

[1]. Laplante M, et al.mTOR signaling at a glance.J Cell Sci. 2009 Oct 15;122(Pt 20):3589-94. 
[2]. Zoncu R, et al. mTOR: from growth signal integration to cancer, diabetes and ageing.Nat Rev Mol Cell Biol. 2011 Jan;12(1):21-35. 
[3]. Johnson SC, et al. mTOR is a key modulator of ageing and age-related disease.Nature. 2013 Jan 17;493(7432):338-45.
[4]. Shimobayashi M, et al. Making new contacts: the mTOR network in metabolism and signalling crosstalk.Nat Rev Mol Cell Biol. 2014 Mar;15(3):155-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.